Ensemble Discovery Cambridge, MA - 02139

Ensemble Discovery is categorized under Commercial Medical Research in Cambridge, MA and active since 2004.

Ensemble Discovery was established in 2004, and today employs 1 to 4, earning Unknown per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number 5417110 by the NAICS.

If you are seeking more information, feel free to contact Michael Taylor, Chief Executive Officer at the company’s single location by writing to 99 Erie St # 1, Cambridge, Massachusetts MA 02139 or by phoning (617) 492-6977. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Ensemble Discovery
Contact Person: Michael Taylor, Chief Executive Officer
Address: 99 Erie St # 1, Cambridge, Massachusetts 02139
Phone Number: (617) 492-6977
Website Address: ensemblediscovery.com
Annual Revenue (USD): Unknown
Founded: 2004
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Commercial Medical Research
SIC Code: 8731
NAICS Code: 5417110
Share This Business:

Ensemble Discovery was started in 2004 to provide professional Commercial Medical Research under the SIC code 8731 and NAICS code 5417110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.

Feel free to contact Michael Taylor, Chief Executive Officer for inquiries that concern Ensemble Discovery by calling the company number (617) 492-6977, as your correspondence is most welcome. Additionally, the physical location of the single location of Ensemble Discovery can be found at the coordinates 42.359,-71.10583 as well as the street address 99 Erie St # 1 in Cambridge, Massachusetts 02139.

For its online presence, you may visit Ensemble Discovery’s website at ensemblediscovery.com and engage with its social media outlets through on Twitter and on Facebook.